» Articles » PMID: 20398344

Role of Carnitine in Disease

Overview
Publisher Biomed Central
Date 2010 Apr 20
PMID 20398344
Citations 227
Authors
Affiliations
Soon will be listed here.
Abstract

Carnitine is a conditionally essential nutrient that plays a vital role in energy production and fatty acid metabolism. Vegetarians possess a greater bioavailability than meat eaters. Distinct deficiencies arise either from genetic mutation of carnitine transporters or in association with other disorders such as liver or kidney disease. Carnitine deficiency occurs in aberrations of carnitine regulation in disorders such as diabetes, sepsis, cardiomyopathy, malnutrition, cirrhosis, endocrine disorders and with aging. Nutritional supplementation of L-carnitine, the biologically active form of carnitine, is ameliorative for uremic patients, and can improve nerve conduction, neuropathic pain and immune function in diabetes patients while it is life-saving for patients suffering primary carnitine deficiency. Clinical application of carnitine holds much promise in a range of neural disorders such as Alzheimer's disease, hepatic encephalopathy and other painful neuropathies. Topical application in dry eye offers osmoprotection and modulates immune and inflammatory responses. Carnitine has been recognized as a nutritional supplement in cardiovascular disease and there is increasing evidence that carnitine supplementation may be beneficial in treating obesity, improving glucose intolerance and total energy expenditure.

Citing Articles

Trimethylamine N-oxide (TMAO) acutely alters ionic currents but does not increase cardiac cell death.

Esposito S, McGuinness L, Sharma P, Chadwick A, Rainbow R Front Physiol. 2025; 16:1505813.

PMID: 40017801 PMC: 11865236. DOI: 10.3389/fphys.2025.1505813.


Assessing the Roles of Retinol, Vitamin K2, Carnitine, and Creatine in Plant-Based Diets: A Narrative Review of Nutritional Adequacy and Health Implications.

Goldman D, Warbeck C, Barbaro R, Khambatta C, Nagra M Nutrients. 2025; 17(3).

PMID: 39940383 PMC: 11820685. DOI: 10.3390/nu17030525.


Metabolomics in juvenile idiopathic arthritis: A distinct profile in patients under methotrexate.

Tomioka R, Ferreira G, Aikawa N, Maciel G, Junior J, Baracat E Clinics (Sao Paulo). 2025; 80:100522.

PMID: 39879909 PMC: 11814531. DOI: 10.1016/j.clinsp.2024.100522.


Evaluation of L-carnitine's protective properties against AlCl3-induced brain, liver, and renal toxicity in rats.

Alqhtani H PLoS One. 2025; 20(1):e0317939.

PMID: 39854541 PMC: 11759994. DOI: 10.1371/journal.pone.0317939.


Revisiting the Role of Carnitine in Heart Disease Through the Lens of the Gut Microbiota.

Demarquoy J Nutrients. 2024; 16(23.

PMID: 39683637 PMC: 11644639. DOI: 10.3390/nu16234244.


References
1.
Rebouche C . Kinetics, pharmacokinetics, and regulation of L-carnitine and acetyl-L-carnitine metabolism. Ann N Y Acad Sci. 2004; 1033:30-41. DOI: 10.1196/annals.1320.003. View

2.
Spiekerkoetter U, Huener G, Baykal T, Demirkol M, Duran M, Wanders R . Silent and symptomatic primary carnitine deficiency within the same family due to identical mutations in the organic cation/carnitine transporter OCTN2. J Inherit Metab Dis. 2003; 26(6):613-5. DOI: 10.1023/a:1025968502527. View

3.
Konig S, Siemes H, Blaker F, Boenigk E, Hanefeld F, Haas N . Severe hepatotoxicity during valproate therapy: an update and report of eight new fatalities. Epilepsia. 1994; 35(5):1005-15. DOI: 10.1111/j.1528-1157.1994.tb02546.x. View

4.
Davanzo W, Ullian M . L-carnitine administration reverses acute mental status changes in a chronic hemodialysis patient with hepatitis C infection. Clin Nephrol. 2002; 57(5):402-5. View

5.
Wanner C, Horl W . Carnitine abnormalities in patients with renal insufficiency. Pathophysiological and therapeutical aspects. Nephron. 1988; 50(2):89-102. DOI: 10.1159/000185137. View